EHAB — Enhabit Inc.
NYSE · Healthcare · Medical Care Facilities
$13.80
+$0.01 (+0.07%)
Enhabit Inc. (EHAB) is a medical care facilities company listed on NYSE. It is led by Barbara Ann Jacobsmeyer B.S., M.A., P.T., based in 6688 North Central Expressway, Dallas, TX, United States, 75206, with about 10,800 employees. Enhabit, Inc. provides home health and hospice services in the United States. The Home Health segment offers nursing care; physical, occupational, and speech therapy; medical and social work; and home health aide services. This segment also provides patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care, and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery or injury, and respiratory diseases; and counseling for patients and their families regarding financial, personal, and social concerns that arise from a patient's health-related problems. Its Hospice segment offers nursing care; pain and symptom management; palliative and dietary counseling; social worker visits; spiritual counseling; and family member bereavement counseling to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is headquartered in Dallas, Texas.
Latest reported EHAB revenue for 2025-09-30 was $263.6M. Net income was $11.6M. Revenue was down 0.9% from 2025-06-30 to 2025-09-30. EHAB currently screens at market cap $706.9M.
Use this EHAB page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the EHAB quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the EHAB SEC filings page. Lician reads the product cache first so this HTML stays unique to Enhabit Inc. even when a live quote feed is slow.
About Enhabit Inc.
Enhabit, Inc. provides home health and hospice services in the United States. The Home Health segment offers nursing care; physical, occupational, and speech therapy; medical and social work; and home health aide services. This segment also provides patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care, and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery or injury, and respiratory diseases; and counseling for patients and their families regarding financial, personal, and social concerns that arise from a patient's health-related problems. Its Hospice segment offers nursing care; pain and symptom management; palliative and dietary counseling; social worker visits; spiritual counseling; and family member bereavement counseling to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is headquartered in Dallas, Texas.
EHAB Key Statistics
Market Cap
$706.91M
Volume
652,845
Previous Close
$13.79
Day Range
$13.79 – $13.81
P/B Ratio
1.28
EPS
-$3.11
Revenue
$1.03B
Net Income
-$154.00M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
-1.1%
Profit Margin
-14.9%
Employees
10,800
EHAB Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $1.03B | $1.05B | $1.07B | $1.11B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$154.00M | -$79.00M | -$38.30M | $112.90M |
| EPS (Diluted) | -$3.11 | -$1.61 | -$0.81 | $2.24 |
Total Assets
$1.23B
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$28.40M
Operating Cash Flow
$51.20M
Free Cash Flow
$0.00
Enhabit Inc. Company Information
- President, CEO & Director
- Barbara Ann Jacobsmeyer B.S., M.A., P.T.
- Headquarters
- 6688 North Central Expressway, Dallas, TX, United States, 75206
- Website
- www.ehab.com
- Phone
- 214 239 6500
- IPO / Founded
- 2022-07-01
- Sector
- Healthcare
- Industry
- Medical Care Facilities